The interaction between dietary inflammatory index and 6 P21 rs2010963 gene variants in metabolic syndrome
- 5 Downloads
The Vascular endothelial growth factor (VEGF) regulates endothelial cell proliferation, migration and angiogenesis, promotes vascular and capillary permeability and also is involved in inflammation. VEGF gene has been suggested to play an important role in the pathogenesis of metabolic syndrome. The aim of this study was to investigate the association between inflammatory potential of a diet and + 405 VEGF C/G (rs2010963) polymorphism and metabolic components in patients with metabolic syndrome.
One hundred fifty patients with metabolic syndrome and fifty healthy individuals were enrolled. A semi-quantitative food-frequency questionnaire (FFQ) was used for dietary assessments and dietary inflammatory index (DII) calculation. Biochemical assays including fasting serum glucose (FSG), serum insulin, matrix metalloproteinase-3 (MMP-3), liver enzymes and lipid profile were measured. Polymerase chain reaction-restriction fragments length polymorphism (PCR-RFLP) method was used for the determination of gene polymorphism.
In the current study, patients with metabolic syndrome had higher serum low density lipoprotein (LDL) and lower high density lipoprotein (HDL) concentrations compared with healthy subjects. Patients with lower DII quartiles and lower inflammatory potential of the diet had lower waist to hip ratio (WHR) and lower diastolic blood pressure (DBP) compared with patients in higher DII quartiles (P < 0.05). Moreover, patients and healthy subjects in second quartile of DII had significantly higher aspartate aminotransferase (AST) and alanine aminotransferase (ALT) concentrations compared with subjects in the first quartile; also healthy subjects in third quartile had significantly higher triglyceride (TG) and total cholesterol (TC) concentrations compared with subjects in second quartile (P < 0.05). Among different genotypes of 6 P21 rs2010963 gene variants in patients with metabolic syndrome, CC genotype indicated the highest DII compared with other genotypes (P < 0.05).
The current study revealed the association between DII and metabolic risk factors of metabolic syndrome.
Level of evidence
Level III, case-control analytic study.
KeywordsDietary Inflammatory Index Vascular endothelial growth factor Metabolic syndrome Genotype
Analysis of variance
Coronary artery disease
High-density lipoprotein cholesterol
Low-density lipoprotein cholesterol
Tumor necrosis factor-α
Dietary inflammatory index
Fasting serum glucose
Polymerase chain reaction-restriction fragments length polymorphism
Tehran lipid and glucose study
Vascular endothelial growth factor
- NCEP-ATP III
National Cholesterol Education Program’s Adult Treatment Panel III
We thank all of the study participants.
All authors read and approved the final version of the manuscript. MAF designed the idea of the project, performed the statistical analysis, wrote the first draft of the manuscript and revised it, MV was involved in manuscript revision and LN and ZN both were involved in the data collection, laboratory assessments and manuscript drafting.
The work has been granted by a grant from Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Compliance with ethical standards
The study protocol has been approved by the ethics committee of the Tabriz University of Medical Sciences.
All of the participants signed and approved a written informed consent before participation in the study.
Conflict of interest
The authors declare that there is no conflict of interest.
This work is the first study evaluates the gene-nutrient interaction from the perspective of DII-gene interactions.
- 2.National Cholesterol Education Program (NCEP) (2002) Expert panel on detection and treatment of high blood cholesterol in adults. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106(25):3143–421. https://doi.org/10.1161/circ.106.25.3143
- 3.Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112(17):2735–2752. https://doi.org/10.1161/circulationaha.105.169404 CrossRefGoogle Scholar
- 17.Barazzoni R, Gortan Cappellari G, Palus S, Vinci P, Ruozi G, Zanetti M, Semolic A, Ebner N, von Heahling S, Sinagra G, Giacca M, Springer J (2017) Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure. J Cachexia Sarcopenia Muscle. https://doi.org/10.1002/jcsm.12254 Google Scholar
- 29.Vural P, Kusku-Kiraz Z, Dogru-Abbasoglu S, Cil EKB, Uysal M (2010) Vascular endothelial growth factor +405G/C, −460 T/C and −2578 A/C polymorphisms are not associated with insulin resistance in polycystic ovary syndrome. Int J Immunogenet 37(4):239–243. https://doi.org/10.1111/j.1744-313X.2010.00915.x CrossRefGoogle Scholar
- 30.Badr Mohammed S, Al-awadi S, Algenabi A (2013) Vascular endothelial growth factor +405 G/C polymorphism and diabetic retinopathy. Int J Adv Res 1(8):278–286Google Scholar
- 32.Moradzadegan A, Vaisi-Raygani A, Nikzamir A, Rahimi Z (2015) Angiotensin converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+405G/C; rs2010963) in type II diabetic patients: association with the risk of coronary artery disease. J Renin Angiotensin Aldosterone Syst 16(3):672–680. https://doi.org/10.1177/1470320313497819 CrossRefGoogle Scholar
- 33.Van-der Meer P, De-Boer RA, White HL, van-der Steege G, Hall AS, Voors AA et al (2005) The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J Card Fail 11:279–284. https://doi.org/10.1016/j.cardfail.2004.11.006 CrossRefGoogle Scholar
- 34.Kanaki T, Bujo H, Mori S, Yanjuan Z, Takahashi K, Yokote K et al (2002) Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. Biochem Biophys Res Commun 294:231–237. https://doi.org/10.1016/S0006-291X(02)00468-0 CrossRefGoogle Scholar
- 35.Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO (1992) Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer 52:4942–4947Google Scholar
- 40.Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV (2007) Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium 14:193–198. https://doi.org/10.1080/10623320701606731 CrossRefGoogle Scholar
- 42.Goncalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM et al (2009) Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome. Clin Chim Acta 403(1–2):173–177. https://doi.org/10.1016/j.cca.2009.02.013 CrossRefGoogle Scholar
- 45.Sokhanvar S, Khoshi A, Hajiaghaei S, Mousavinasab N, Golmohammadi Z (2012) Association between Apo lipoprotein B levels at admission of patients and short-term morbidity and mortality after myocardial infarction. J Cardiovasc Thorac Res 4(3):61–64. https://doi.org/10.5681/jcvtr.2012.015 Google Scholar
- 46.Farhangi MA, Najafi M, Jafarabadi MA, Jahangiry L (2017) Mediterranean dietary quality index and dietary phytochemical index among patients candidate for coronary artery bypass grafting (CABG) surgery. BMC Cardiovasc Disord 17(1):114–120. https://doi.org/10.1186/s12872-017-0544-z CrossRefGoogle Scholar
- 52.Orchard T, Yildiz V, Steck SE, Hebert JR, Ma Y, Cauley JA et al (2017) Dietary inflammatory index, bone mineral density, and risk of fracture in postmenopausal women: results from the women’s health initiative. J Bone Miner Res 32(5):1136–1146. https://doi.org/10.1002/jbmr.3070 CrossRefGoogle Scholar
- 54.Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Caan B et al (2015) The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women’s Health Initiative. Cancer Causes Control 26(3):399–408. https://doi.org/10.1007/s10552-014-0515-y CrossRefGoogle Scholar
- 56.Alkerwi AA, Shivappa N, Crichton G, Hébert JR (2014) No significant independent relationships with cardiometabolic biomarkers were detected in the Observation of Cardiovascular Risk Factors in Luxembourg study population. Nutr Res 34(12):1058–1065. https://doi.org/10.1016/j.nutres.2014.07.017 CrossRefGoogle Scholar
- 57.Carvalho CA, Silva AAM, Assuncao MCF, Fonseca PCA, Barbieri MA, Bettiol H et al (2019) The dietary inflammatory index and insulin resistance or metabolic syndrome in young adults. Nutrition (Burbank, Los Angeles County, Calif) 58:187–193. https://doi.org/10.1016/j.nut.2018.07.014 CrossRefGoogle Scholar
- 60.Neufcourt L, Assmann KE, Fezeu LK, Touvier M, Graffouillère L, Shivappa N et al (2015) Prospective association between the dietary inflammatory index and metabolic syndrome: findings from the SU.VI.MAX study. Nutr Metab Cardiovasc Dis 25(11):988–996. https://doi.org/10.1016/j.numecd.2015.09.002 CrossRefGoogle Scholar
- 62.Farhangi MA, Jahangiry L, Mirinazhad MM, Shojaeezade D, Montazeri A, Yaghoubi A (2017) A web-based interactive lifestyle modification program improves lipid profile and serum adiponectin concentrations in patients with metabolic syndrome: the “Red Ruby” study. Int J Diabetes Dev Ctries 37(1):21–30. https://doi.org/10.1007/s13410-015-0395-z CrossRefGoogle Scholar
- 66.Farzi A, Hagh MF (2014) Association between Vascular Endothelial Growth Factor (VEGF) + 405 C/G polymorphism and hypertension in North West of Iran. Int Res J Appl Basic Sci 8(1):122–125Google Scholar
- 67.Azimi-Nezhad M, Mirhafez SR, Stathopoulou MG, Murray H, Ndiaye NC, Bahrami A et al (2018) The relationship between vascular endothelial growth factor cis- and trans-acting genetic variants and metabolic syndrome. Am J Med Sci 355(6):559–565. https://doi.org/10.1016/j.amjms.2018.03.009 CrossRefGoogle Scholar
- 71.Wirth M, Burch J, Shivappa N, Violanti JM, Burchfiel CM, Fekedulegn D et al (2014) Association of a dietary inflammatory index with inflammatory indices and the metabolic syndrome among police officers. J Occup Environ Med 56(9):986–989. https://doi.org/10.1097/JOM.0000000000000213 CrossRefGoogle Scholar
- 72.Woudenbergh GJ, Theofylaktopoulou D, Kuijsten A, Ferreira I, van Greevenbroek MK, van der Kallen CJ et al (2013) Adapted dietary inflammatory index and its association with a summary score for low-grade inflammation and markers of glucose metabolism: the Cohort study on Diabetes and Atherosclerosis Maastricht (CODAM) and the Hoorn study. Am J Clin Nutr 98(6):1533–1542. https://doi.org/10.3945/ajcn.112.056333 CrossRefGoogle Scholar
- 77.Borini P, Guimarães RC (1999) Indicators of inflammation and cellular damage in chronic asymptomatic or oligosymptomatic alcoholics: correlation with alteration of bilirubin and hepatic and pancreatic enzymes. Revista do Hospital das Clínicas 54(2):53–60. https://doi.org/10.1590/S0041-87811999000200005 CrossRefGoogle Scholar
- 78.Jaeschke H (2006) Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 290(6):G1083–G1088. https://doi.org/10.1152/ajpgi.00568.2005 CrossRefGoogle Scholar
- 82.Steck SE, Shivappa N, Tabung FK, Harmon BE, Wirth MD, Hurley TG, Hebert JR (2014) The dietary inflammatory index: a new tool for assessing diet quality based on inflammatory potential. Digest 49(3):1–10Google Scholar